Equities

Bactiguard Holding AB

Bactiguard Holding AB

Actions
Health CareMedical Equipment and Services
  • Price (SEK)37.00
  • Today's Change0.20 / 0.54%
  • Shares traded1.13k
  • 1 Year change-38.33%
  • Beta-0.0916
Data delayed at least 15 minutes, as of Nov 08 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy0
Outperform0
Hold0
Sell0
Strong Sell1

Share price forecast in SEK

The one analyst offering a 12 month price target expects Bactiguard Holding AB share price to fall to 35.00 in the next year from the last price of 37.00.
High-5.4%35.00
Med-5.4%35.00
Low-5.4%35.00

Earnings history & estimates in SEK

On Nov 05, 2020, losses of -0.48 per share.
The next earnings announcement is expected on Feb 06, 2025.
Average growth rate-263.87%
Bactiguard Holding AB reported annual 2023 losses of -3.95 per share on Feb 08, 2024.
Average growth rate-68.07%
More ▼

Revenue history & estimates in SEK

Bactiguard Holding AB (publ) had revenues for the full year 2023 of 223.17m. This was 11.96% below the prior year's results.
Average growth rate+4.98%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.